1981
DOI: 10.1111/j.1445-5994.1981.tb03744.x
|View full text |Cite
|
Sign up to set email alerts
|

Captopril-induced Agranulocytosis in Systemic Sclerosis

Abstract: Captopril‐induced agranulocytosis in systemic sclerosis. M. A. Watson, N. J. Radford, B. P. McGrath, G. W. Swinton and J. W. M. Agar, Aust. N.Z. J. Med., 1981, 11, pp. 79–81. A 25 year old woman with systemic sclerosis developed severe but reversible agranulocytosis seven weeks after commencing treatment with Captopril for severe hypertension and renal impairment The evidence suggests that the agranulocytosis was caused by Captopril

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1983
1983
2016
2016

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 16 publications
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…Agranulocytosis has been observed in several cases. All these were transient and reversible by dis continuation of the medication [3][4][5][6][7], 1 patient devel oped fatal pancytopenia but he was suspected of hav ing an underlying blood dyscrasia [8]. We wish now to report a case of transient aplastic anemia associated with captopril administration.…”
Section: Introductionmentioning
confidence: 99%
“…Agranulocytosis has been observed in several cases. All these were transient and reversible by dis continuation of the medication [3][4][5][6][7], 1 patient devel oped fatal pancytopenia but he was suspected of hav ing an underlying blood dyscrasia [8]. We wish now to report a case of transient aplastic anemia associated with captopril administration.…”
Section: Introductionmentioning
confidence: 99%